Resumen
Se efectúa una revisión de los artículos más interesantes de infecciones respiratorias, publicados en el último trimestre del año 2009 y en 2010. En cuanto a las bronquiectasias, destacan las Guidelines de la British Thoracic Society, así como diversos artículos de la evolución natural del proceso y el impacto de las reagudizaciones de ésta, así como del tratamiento inhalatorio antibiótico de las bronquiectasias. Con respecto a la tuberculosis, es recomendable señalar el documento de consenso SEPAR-SEIMC para el manejo de la tuberculosis, así como las publicaciones sobre la utilización de interferón-gamma en el diagnóstico de infección tuberculosa. Las nuevas recomendaciones SEPAR de neumonía adquirida en la comunidad (NAC) se han publicado muy recientemente, y junto con ellas destacan estudios de etiología viral de las NAC, impacto del tratamiento corticoideo en las neumonías, duración del tratamiento antibiótico y medidas preventivas de neumonías, tanto comunitarias como nosocomiales.
Palabras clave: Guidelines, Reagudizaciones de bronquiectasias, Interferón-gamma en diagnóstico de infección tuberculosa, Etiología viral en neumonías, Corticoides y neumonía adquirida en la comunidad
Abstract
We review the most interesting articles on respiratory infections published in the last trimester of 2009 and in 2010. Notable publications in bronchiectasis were the Guidelines of the British Thoracic Society, as well as several articles on the natural course of the process, the impact of exacerbations on the course of the disease, and treatment with inhaled antibiotics. Other notable publications were the SEPAR-SEIMC consensus document for the management of tuberculosis and articles on the use of interferon-gamma in the diagnosis of tuberculosis infection. The new recommendations of the Spanish Society of Pneumology and Thoracic Surgery on community-acquired pneumonia have recently been published. Equally important are studies on the viral etiology of community-acquired pneumonia, the impact of corticosteroid treatment in pneumonia, the duration of antibiotic therapy and preventive measures in both community-acquired and nosocomial pneumonia.
Keywords: Guidelines, Bronchiectasis exacerbations, Interferon gamma in the diagnosis of tuberculosis infection, Viral etiology in pneumonia, Corticosteroids and community-acquired pneumonia
Bibliografía
- 1.Pasteur M.C., Milton D., Hill A.T., on behalf of the British Thoracic Society Bronchiectasis (non-CF) Guidelines Group British Thoracic Society for non-CF bronchiectasis. Thorax. 2010;65:i1–i58. doi: 10.1136/thx.2010.136119. [DOI] [PubMed] [Google Scholar]
- 2.Munro KA, Reed PW, Joyce H, et al. Do New Zeland children with non-cystic fibrosis bronchiectasis show disease progression? Pediatr Pneumol. 2010 Aug 17. [Epub ahead of print]. [DOI] [PubMed]
- 3.Kapur N., Masters I.B., Chang A.B. Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis. What influencies lung function stability? Chest. 2010;138:158–164. doi: 10.1378/chest.09-2932. [DOI] [PubMed] [Google Scholar]
- 4.Seits A.E., Olivier K.N., Steiner C.A., Montes de Oca R., Holland S.M., Prevots R. Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993–2006. Chest. 2010;138:944–949. doi: 10.1378/chest.10-0099. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Roberts H.J., Hubbard R. Trends in bronchiectasis mortality in England and Wales. Respir Med. 2010;104:981–985. doi: 10.1016/j.rmed.2010.02.022. [DOI] [PubMed] [Google Scholar]
- 6.Murray MP, Govan JRW, Doherty CJ, et al. A randomized controlled trial of nebulized gentamicin in non cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2010 Sep 24. [Epub ahead of print]. [DOI] [PubMed]
- 7.Dhar R., Anwar G.A., Bourke S.C. Efficacy of nebulised colomycin in patients with non-cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosa. Thorax. 2010;65:553. doi: 10.1136/thx.2008.112284. [DOI] [PubMed] [Google Scholar]
- 8.Palop-Cervera M., De Diego A., Martínez-Moragón E., Cortijo J., Fullana J., León M. Estudio de marcadores de inflamación en el aire exhalado de pacientes con bronquiectasias no asociadas a fibrosis quística. Arch Bronconeumol. 2009;45:597–602. doi: 10.1016/j.arbres.2009.09.007. [DOI] [PubMed] [Google Scholar]
- 9.Martínez-García MA, Soler-Cataluña JJ, Donat-Sanz Y, Catalán Agramunt M, Ballestín J, et al. Factors associated with bronchiectasis in chronic obstructive pulmonary disease patients. Chest. 2010. En prensa.
- 10.Disponible en: http://www.who.int/tb/publications/global_report/2010/gtbr10.pdf
- 11.Boehme C.C., Nabeta P., Hillemann D., Nicol M.P., Shenai S., Krapp F. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363:1005–1015. doi: 10.1056/NEJMoa0907847. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.González-Martín J., García-García J.M., Anibarro L., Vidal R., Esteban J., Blanquer R. Documento de consenso sobre diagnóstico, tratamiento y prevención de la tuberculosis. Arch Bronconeumol. 2010;46:255–274. doi: 10.1016/j.arbres.2010.02.010. [DOI] [PubMed] [Google Scholar]
- 13.Erkens C.GM., Kamphorst M., Abubakar I., Bothamley G.H., Chemtob D., Haas W. Tuberculosis contact investigation in low prevalence countries: a European consensus. Eur Resp J. 2010;36:925–949. doi: 10.1183/09031936.00201609. [DOI] [PubMed] [Google Scholar]
- 14.Diel R, Goletti D, Ferrara G, Bothamley GH, Cirillo D, Kampmann B, et al. Interferon-gamma release assays for the diagnosis of latent M. tuberculosis infection: A systematic review and meta-analysis. Eur Respir J. 2010. [Epub ahead of print]. [DOI] [PubMed]
- 15.Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori GB, et al. Interferon-gamma release assays for the diagnosis of active tuberculosis: A systematic review and meta-analysis. Eur Respir J. 2010; [Epub ahead of print]. [DOI] [PubMed]
- 16.Mazurek G.R., Jereb J., Vernon A., Lobue P., Goldberg S., Castro K. Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection, United States. MMWR Recomm Rep. 2010;59:1–26. [PubMed] [Google Scholar]
- 17.Canadian Tuberculosis Committee (CTC) Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS) Can Commun Dis Rep. 2008;34:1–13. [PubMed] [Google Scholar]
- 18.Menéndez R., Torres A., Aspa J., Capelastegui A., Prat C., Rodríguez de Castro F. Neumonía adquirida en la comunidad. Nueva normativa de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR) Arch Bronconeumol. 2010;46:543–548. doi: 10.1016/j.arbres.2010.06.014. [DOI] [PubMed] [Google Scholar]
- 19.Lieberman D., Shimoni A., Shemer-Avni Y., Keren-Naos A., Shtainberg R., Lieberman D. Respiratory viruses in adults with community-acquired pneumonia. Chest. 2010;138:811–816. doi: 10.1378/chest.09-2717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Malo de Molina R., Mortensen E.M., Restrepo M.I., Copeland L.A., Pugh M.J.V., Anzueto A. Inhaled corticosteroids use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia. Eur Respir J. 2010;36:751–757. doi: 10.1183/09031936.00077509. [DOI] [PubMed] [Google Scholar]
- 21.Snijders D., Daniels J., De Graaf C.S., Van der Werf T.S., Boersma W.G. Efficacy of corticosteroids in community-acquired pneumonia. A randomized double-blinded clinical trial. Am J Respir Crit Care. 2010;181:975–982. doi: 10.1164/rccm.200905-0808OC. [DOI] [PubMed] [Google Scholar]
- 22.Davies A., Jones D., Bailey M., Beca J., Bellomo R., Blackwell N. Extracorporeal membrane oxygenation 2009 influenza A (H1N1) acute respiratory distress syndrome. JAMA. 2009;302:1888–1895. doi: 10.1001/jama.2009.1535. [DOI] [PubMed] [Google Scholar]
- 23.Aliberti S., Blasi F., Zanaboni A.M., Peyrani P., Tarsia P., Gaito S. Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia. Eur Respir J. 2010;36:128–134. doi: 10.1183/09031936.00130909. [DOI] [PubMed] [Google Scholar]
- 24.Falguera M., Ruiz-González A., Schoenenberger J.A., Touzón C., Gázquez I., Galindo C. Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia. Thorax. 2010;65:101–106. doi: 10.1136/thx.2009.118588. [DOI] [PubMed] [Google Scholar]
- 25.Waterer G.W., Rello J. Management of community-acquired pneumonia in adults. Am J Respir Crit Care Med. 2010 doi: 10.1164/rccm.201002-0272CI. DOI 10.1164/rccm.201002-0272CI. [DOI] [PubMed] [Google Scholar]
- 26.Johnstone J., Eurich D.T., Minhas J.K., Marrie T.J., Majumdar S.R. Impact of the pneumococcal vaccine on long-term morbidity and mortality of adults at high risk for pneumonia. Clin Infect Dis. 2010;51:15–22. doi: 10.1086/653114. [DOI] [PubMed] [Google Scholar]
- 27.Díaz L.D., Llauradó M., Rello J., Restrepo M.I. Prevención no farmacológica de la neumonía asociada a ventilación mecánica. Arch Bronconeumol. 2010;46:188–195. doi: 10.1016/j.arbres.2009.08.001. [DOI] [PubMed] [Google Scholar]